Entera Bio Ltd. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Kesselman & Kesselman, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.46 USD | -3.15% | +13.89% | +310.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+310.00% | 87.28M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- ENTX Stock
- News Entera Bio Ltd.
- Entera Bio Ltd. Auditor Raises 'Going Concern' Doubt